OTCMKTS:CHOOF

Choom Competitors

$0.09
0.00 (-1.85 %)
(As of 04/14/2021 03:55 PM ET)
Add
Compare
Today's Range
$0.08
Now: $0.09
$0.10
50-Day Range
$0.09
MA: $0.11
$0.13
52-Week Range
$0.05
Now: $0.09
$0.17
Volume1.45 million shs
Average Volume933,908 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Choom (OTCMKTS:CHOOF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying CHOOF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Choom, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Abacus Health Products (OTCMKTS:ABAHF) and Choom (OTCMKTS:CHOOF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Abacus Health Products and Choom, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
Choom0000N/A

Profitability

This table compares Abacus Health Products and Choom's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
ChoomN/AN/AN/A

Valuation & Earnings

This table compares Abacus Health Products and Choom's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
ChoomN/AN/AN/AN/AN/A

Acreage (OTCMKTS:ACRGF) and Choom (OTCMKTS:CHOOF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk.

Valuation and Earnings

This table compares Acreage and Choom's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
ChoomN/AN/AN/AN/AN/A

Profitability

This table compares Acreage and Choom's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
ChoomN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for Acreage and Choom, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Choom0000N/A

Acreage presently has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher possible upside, equities analysts plainly believe Acreage is more favorable than Choom.

Summary

Acreage beats Choom on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Choom (OTCMKTS:CHOOF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Valuation and Earnings

This table compares Applied Biosciences and Choom's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
ChoomN/AN/AN/AN/AN/A

Profitability

This table compares Applied Biosciences and Choom's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
ChoomN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Applied Biosciences and Choom, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Choom0000N/A

Ayr Strategies (OTCMKTS:AYRSF) and Choom (OTCMKTS:CHOOF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Valuation and Earnings

This table compares Ayr Strategies and Choom's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ayr StrategiesN/AN/AN/AN/AN/A
ChoomN/AN/AN/AN/AN/A

Profitability

This table compares Ayr Strategies and Choom's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ayr StrategiesN/AN/AN/A
ChoomN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Ayr Strategies and Choom, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ayr Strategies01602.86
Choom0000N/A

Ayr Strategies presently has a consensus target price of $34.8571, suggesting a potential upside of 63.96%. Given Ayr Strategies' higher probable upside, equities analysts clearly believe Ayr Strategies is more favorable than Choom.

Summary

Ayr Strategies beats Choom on 2 of the 2 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Choom (OTCMKTS:CHOOF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Valuation and Earnings

This table compares Can B and Choom's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Can BN/AN/AN/AN/AN/A
ChoomN/AN/AN/AN/AN/A

Profitability

This table compares Can B and Choom's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Can BN/AN/AN/A
ChoomN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Can B and Choom, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Can B0000N/A
Choom0000N/A

Cansortium (OTCMKTS:CNTMF) and Choom (OTCMKTS:CHOOF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Valuation and Earnings

This table compares Cansortium and Choom's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CansortiumN/AN/AN/AN/AN/A
ChoomN/AN/AN/AN/AN/A

Profitability

This table compares Cansortium and Choom's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CansortiumN/AN/AN/A
ChoomN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Cansortium and Choom, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cansortium00103.00
Choom0000N/A

Cansortium presently has a consensus target price of $1.20, suggesting a potential upside of 39.67%. Given Cansortium's higher probable upside, equities analysts clearly believe Cansortium is more favorable than Choom.

Summary

Cansortium beats Choom on 2 of the 2 factors compared between the two stocks.


Choom Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84-5.4%$0.00N/A0.00Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77-0.0%$0.00N/A0.00
Applied Biosciences logo
APPB
Applied Biosciences
0.5$0.40-85.0%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
AYRSF
Ayr Strategies
1.4$21.26-0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.52-2.9%$0.00N/A0.00
Cansortium logo
CNTMF
Cansortium
1.1$0.88-2.7%$0.00N/A0.00Decrease in Short Interest
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.18-0.1%$0.00N/A0.00News Coverage
Gap Up
CPHRF
Cipher Pharmaceuticals
1.2$1.06-2.5%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.24-0.8%$0.00N/A0.00News Coverage
Gap Up
Cosmos logo
COSM
Cosmos
0.5$5.75-1.2%$0.00N/A0.00Increase in Short Interest
Cresco Labs logo
CRLBF
Cresco Labs
1.5$12.12-1.4%$0.00N/A0.00Gap Up
Curaleaf logo
CURLF
Curaleaf
1.6$14.36-2.5%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00-23.8%$0.00N/A0.00Decrease in Short Interest
Gap Up
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15-9.9%$0.00N/A0.00Increase in Short Interest
News Coverage
EVIO logo
EVIO
EVIO
0.6$0.00-3.7%$0.00N/A0.00Increase in Short Interest
Gap Up
Flower One logo
FLOOF
Flower One
0.4$0.26-8.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05-1.3%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01-13.9%$0.00N/A0.00Gap Down
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$29.49-1.1%$0.00N/A0.00
GTEC logo
GGTTF
GTEC
0.6$0.62-2.7%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.80-4.0%$0.00N/A0.00Gap Down
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01-7.1%$0.00N/A0.00Decrease in Short Interest
News Coverage
Hexo logo
HYYDF
Hexo
0.6N/AN/A$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.02-1.1%$0.00N/A0.00
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.22-4.5%$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.32-5.4%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04-5.9%$0.00N/A0.00Decrease in Short Interest
News Coverage
Isodiol International logo
ISOLF
Isodiol International
0.4$0.05-2.0%$0.00N/A0.00Gap Down
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.43-4.2%$0.00N/A0.00Decrease in Short Interest
News Coverage
KHTRF
Knight Therapeutics
1.2$4.21-0.2%$0.00N/A0.00News Coverage
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-2.8%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05-11.1%$0.00N/A0.00
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.38-2.9%$0.00N/A0.00Increase in Short Interest
Gap Up
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.32-7.3%$0.00N/A0.00Increase in Short Interest
News Coverage
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$35.33-0.2%$0.00N/A0.00Increase in Short Interest
MJardin Group logo
MJARF
MJardin Group
1.1$0.07-7.2%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
MYHI
Mountain High Acquisitions
0.5$0.02-12.6%$0.00N/A0.00Decrease in Short Interest
Gap Down
PHCEF
Pharmacielo
0.7$1.40-7.9%$0.00N/A0.00News Coverage
Gap Up
Plus Products logo
PLPRF
Plus Products
1.1$0.55-0.3%$0.00N/A0.00Decrease in Short Interest
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00-7.4%$0.00N/A0.00
PCYN
Procyon
0.4$0.60-16.7%$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01-0.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
SANP
Santo Mining
0.5$0.01-3.8%$0.00N/A0.00News Coverage
Gap Down
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$13.23-0.4%$0.00N/A0.00High Trading Volume
Increase in Short Interest
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40-0.0%$0.00N/A0.00
TerrAscend logo
TRSSF
TerrAscend
1.7$10.58-9.3%$0.00N/A0.00Increase in Short Interest
The Flowr logo
FLWPF
The Flowr
1.5$0.25-0.2%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.31-0.5%$0.00N/A0.00
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.